Search the Community
Showing results for tags 'ehp-101'.
Cannabidiol Therapy, EHP-101, Put on Fast Track by FDA. EHP-101, an oral therapy based on cannabidiol (CBD), has been placed on fast track development by the U.S. Food and Drug Administration (FDA) as a potential treatment of systemic scleroderma. Scleroderma News, 03/06/2020. (Also see Endocannabinoid System) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.